These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1378459)

  • 1. Mapping human T cell epitopes on phospholipase A2: the major bee-venom allergen.
    Dhillon M; Roberts C; Nunn T; Kuo M
    J Allergy Clin Immunol; 1992 Jul; 90(1):42-51. PubMed ID: 1378459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy.
    Kämmerer R; Chvatchko Y; Kettner A; Dufour N; Corradin G; Spertini F
    J Allergy Clin Immunol; 1997 Jul; 100(1):96-103. PubMed ID: 9257793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy.
    Kämmerer R; Kettner A; Chvatchko Y; Dufour N; Tiercy JM; Corradin G; Spertini F
    Clin Exp Allergy; 1997 Sep; 27(9):1016-26. PubMed ID: 9678833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production.
    Blaser K
    Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To bee or not to be? T-cell responses to bee venom PLA2 in relation to anaphylaxis and immunotherapy.
    McHugh SM
    Clin Exp Allergy; 1997 Sep; 27(9):986-90. PubMed ID: 9678827
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
    Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K
    J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.
    Carballido JM; Carballido-Perrig N; Terres G; Heusser CH; Blaser K
    Eur J Immunol; 1992 Jun; 22(6):1357-63. PubMed ID: 1601030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.
    Corthésy B; Lassus A; Terrettaz J; Tranquart F; Bioley G
    Allergy; 2016 Jul; 71(7):957-66. PubMed ID: 26850222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants and mechanisms of human immune responses to bee venom phospholipase A2.
    Blaser K; Carballido J; Faith A; Crameri R; Akdis C
    Int Arch Allergy Immunol; 1998 Sep; 117(1):1-10. PubMed ID: 9751842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.
    Mori A; Thomas P; Tagaya Y; Iijima H; Grey H; Ishizaka K
    Int Immunol; 1993 Aug; 5(8):833-42. PubMed ID: 7691164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial.
    Fellrath JM; Kettner A; Dufour N; Frigerio C; Schneeberger D; Leimgruber A; Corradin G; Spertini F
    J Allergy Clin Immunol; 2003 Apr; 111(4):854-61. PubMed ID: 12704369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy.
    Kemeny DM; Harries MG; Youlten LJ; Mackenzie-Mills M; Lessof MH
    J Allergy Clin Immunol; 1983 May; 71(5):505-14. PubMed ID: 6601672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis.
    von Garnier C; Astori M; Kettner A; Dufour N; Heusser C; Corradin G; Spertini F
    Eur J Immunol; 2000 Jun; 30(6):1638-45. PubMed ID: 10898500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2.
    Carballido JM; Carballido-Perrig N; Kägi MK; Meloen RH; Wüthrich B; Heusser CH; Blaser K
    J Immunol; 1993 Apr; 150(8 Pt 1):3582-91. PubMed ID: 7682244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.
    Carballido JM; Carballido-Perrig N; Oberli-Schrämmli A; Heusser CH; Blaser K
    J Allergy Clin Immunol; 1994 Apr; 93(4):758-67. PubMed ID: 8163785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of bee venom Api m 1 IgE epitopes and characterization of corresponding mimotopes.
    Zahirović A; Koren A; Kopač P; Štrukelj B; Korošec P; Lunder M
    J Allergy Clin Immunol; 2019 Feb; 143(2):791-794.e5. PubMed ID: 30315830
    [No Abstract]   [Full Text] [Related]  

  • 18. On the diversity and heterogeneity of H-2(d)-restricted determinants and T cell epitopes from the major bee venom allergen.
    Texier C; Hervé M; Pouvelle S; Ménez A; Maillère B
    Int Immunol; 1999 Aug; 11(8):1313-26. PubMed ID: 10421789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of carbohydrate on phospholipase A2, a bee-venom allergen, in in vivo antigen-specific IgE synthesis in mice.
    Okano M; Nishizaki K; Satoskar AR; Yoshino T; Masuda Y; Harn DA
    Allergy; 1999 Aug; 54(8):811-8. PubMed ID: 10485384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
    Kemeny DM; MacKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH
    J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.